Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Adoptive T-Cell Therapy for Cancer.

Advances in immunology - 1 Jan 2016

Yang James C, Rosenberg Steven A

Abstract excerpt

Recent developments have demonstrated that immunotherapies are capable of achieving durable antitumor responses in patients with metastatic cancer. One modality that has been able to induce durable complete regressions in patients with melanoma has been adoptive cell therapy (ACT). This has slowly been expanded to other cancer types using new approaches such as genetically engineered T-cells and other methods of...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Antigens, Neoplasm
Share to Cell Cycle Checkpoints
Share to Immunotherapy, Adoptive

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Lymphocytes, Tumor-Infiltrating

Share to Mutation

Share to Neoplasms

Share to T-Lymphocytes

Source

Open in PubMed Open full text

Identifiers

PMID: 26923004
DOI: 10.1016/bs.ai.2015.12.006
PMCID: PMC6293459

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 4 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Adoptive T-Cell Therapy for Cancer.PMID 26923004Read ↗

Adoptive cell transfer as personalized immunotherapy for human cancer.Semantic proximity Read ↗

Cell Therapy With TILs: Training and Taming T Cells to Fight Cancer.Semantic proximity Read ↗

Exploiting the curative potential of adoptive T‐cell therapy for cancerSemantic proximity Read ↗

Adoptive T cell therapy of cancerSemantic proximity Read ↗

Engineered T cells for anti-cancer therapySemantic proximity Read ↗

Adoptive immunotherapy for cancer: the next generation of gene‐engineered immune cellsSemantic proximity Read ↗

Cancer immunotherapy for metastasis: past, present and futureSemantic proximity Read ↗

Cancer immunotherapy: broadening the scope of targetable tumours.Semantic proximity Read ↗

Engineered T cells for cancer therapySemantic proximity Read ↗

Adoptive T‐cell therapy for cancer: The era of engineered T cellsSemantic proximity Read ↗

Long-term efficacy of adoptive cell therapy is determined by host CD8 <sup>+</sup> T cells and undermined by lymphodepleting preconditioningSemantic proximity Read ↗

Neoantigen-specific CD4+ tumor-infiltrating lymphocytes are potent effectors identified within adoptive cell therapy products for metastatic melanoma patientsSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.